ESR1 and breast cancer: BHMC has been reported to possess anti-tumor and anti-metastatic properties against ER negative 4T1 breast cancer cells in vivo [8], and anti-invasive properties against ER negative MDA-MB-231 breast cancer cells in vitro [20].